Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'Role of glucagon-like peptide 1 receptor Agonist (GLP1 RA) Dulaglutide on cerebral hemodynamics I... Read More
Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More
Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More
Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Dulaglutide on Re... Read More
Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More
Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More
Tokyo, April 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061363) titled 'A clinical trial of individual psychoeducation to reduce self-stigma of pa... Read More
Tokyo, April 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061269) titled 'Oral Function Development Training Program for the Prevention and Improvem... Read More
Tokyo, April 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061372) titled 'Intervention effects of the Circle of Security Parenting program for fathe... Read More
Tokyo, April 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061371) titled 'Triptans and lasmiditan in patients with migraine attacks associated with ... Read More